Copyright
©The Author(s) 2016.
World J Hepatol. Aug 8, 2016; 8(22): 942-948
Published online Aug 8, 2016. doi: 10.4254/wjh.v8.i22.942
Published online Aug 8, 2016. doi: 10.4254/wjh.v8.i22.942
Variable | MELD < 20 (n = 38) | MELD > 20 (n = 33) |
Age (yr) (mean ± SD) | 47.8 ± 7.8 | 46.2 ± 7.9 |
Sex | ||
Male | 34 (89.5 | 32 (97) |
Female | 4 (10.5) | 1 (3) |
Diagnosis | ||
ESLD | 27 (71.1) | 26 (78.8) |
HCC | 3 (7.9) | 0 |
ESLD + HCC | 8 (21) | 7 (21.2) |
Child-Turcotte-Pugh | ||
A | 0 | 0 |
B | 3 (7.9) | 0 |
C | 35 (92.1) | 33 (100) |
Cold ischemia time (min) | 47 ± 23 | 42 ± 30 |
Warm ischemia time (min) | 54.4 ± 20.2 | 53.7 ± 16.9 |
- Citation: Dabbous H, Sakr M, Abdelhakam S, Montasser I, Bahaa M, Said H, El-Meteini M. Living donor liver transplantation for high model for end-stage liver disease score: What have we learned? World J Hepatol 2016; 8(22): 942-948
- URL: https://www.wjgnet.com/1948-5182/full/v8/i22/942.htm
- DOI: https://dx.doi.org/10.4254/wjh.v8.i22.942